Skip to main content
. 2011 May 11;2011(5):CD008063. doi: 10.1002/14651858.CD008063.pub2

MATCH 1993.

Methods Multisite RCT (9 clinical research units and a coordinating centre).
Participants 1726 US inpatients and outpatients.
Interventions Motivational Enhancement Therapy (MET) vs Cognitive Behavioral Therapy (CBT) vs Twelve‐Step Facilitation Therapy (TSF). Not reported how many people were randomised to each condition.
Outcomes Physiological primary: Gamma‐glutamyl transferase.
Non‐physiological primary: Percent days abstinent, drinks per drinking day, drinking consequences,
Secondary: None.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk "Randomization to treatment was performed using a computerized urn balancing program designed to minimize differences on critical demographic and matching variables".
Allocation concealment (selection bias) Unclear risk Randomization process centrally controlled by the coordination centre.
Blinding (performance bias and detection bias) 
 Patients and providers Low risk No blinding, but most outcomes were physiological and also used to validate self‐reports, and not likely to be influenced by lack of blinding.
Blinding (performance bias and detection bias) 
 Assessors Unclear risk No blinding, but most outcomes were physiological and also used to validate self‐reports, and not likely to be influenced by lack of blinding.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Attrition was less than 10% at the 3, 6, 9, 12, and 15 months follow‐ups in the aftercare and outpatient groups. Balanced. Reasons for 3‐year attrition in the outpatient group given. The authors state that all randomised participants are included in the analyses, but in a results table they included only data for subjects who had non missing values at all three time points.
Selective reporting (reporting bias) Unclear risk Primary outcomes measures (PDA and DDD) reported incompletely (only by graphs). Outcome for drinking consequences only reported in tables for 9‐ and 15 months follow‐up.
Other bias Low risk Collateral report, laboratory tests (blood and urine) as check on self‐report. Breathalyzer at each assessment point. Inclusion criteria contained no planned involvement for additional treatment during the study period. There were no differences between groups at baseline. No additional sources of bias appear to be present.